A whole-genome association study of major determinants for host control of HIV-1

Science

Volumn 317, Issue 5840, 2007, Pages 944-947

  Fellay, Jacques ^a   Shianna, Kevin V ^a   Ge, Dongliang ^a   Colombo, Sara ^b,c   Ledergerber, Bruno ^d   Weale, Mike ^a   Zhang, Kunlin ^b,c   Gumbs, Curtis ^a   Castagna, Antonella ^e   Cossarizza, Andrea ^f   Cozzi Lepri, Alessandro ^g   De Luca, Andrea ^h   Easterbrook, Philippa ⁱ   Francioli, Patrick ^b   Mallal, Simon ^j,k   Martinez Picado, Javier ^l,m   Miro, José M ⁿ   Obel, Niels ^o   Smith, Jason P ^a   Wyniger, Josiane ^b,c   Descombes, Patrick ^p   Antonarakis, Stylianos E ^q   Letvin, Norman L ^r   McMichael, Andrew J ^s   Haynes, Barton F ^t   Telenti, Amalio ^b,c   Goldstein, David B ^a   more..

^a DUKE UNIVERSITY   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e SAN RAFFAELE HOSPITAL   (Italy)

^f UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^g ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^h CATHOLIC UNIVERSITY   (Italy)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j ROYAL PERTH HOSPITAL   (Australia)

^k MURDOCH UNIVERSITY   (Australia)

^l HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^m INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

ⁿ UNIVERSITY OF BARCELONA   (Spain)

^o International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^p UNIVERSITY OF GENEVA   (Switzerland)

^q UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^r HARVARD MEDICAL SCHOOL   (United States)

^s JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^t DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN; NUCLEOTIDYLTRANSFERASE; RNA POLYMERASE 1 SUBUNIT; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN; DISEASE CONTROL; DISEASE RESISTANCE; GENE EXPRESSION; GENETIC VARIATION; GENOMICS; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYMORPHISM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALLELE; ARTICLE; DISEASE COURSE; DRUG TARGETING; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOME; HCP5 GENE; HLA C GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; PHENOTYPE; PRIORITY JOURNAL; RETROVIRUS; RNA GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT PLANNING; VIRUS INHIBITION; VIRUS LOAD; ZNRD1 GENE;

COHORT STUDIES; DISEASE PROGRESSION; DNA-BINDING PROTEINS; FEMALE; GENES, MHC CLASS I; GENOME, HUMAN; HAPLOTYPES; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HLA-C ANTIGENS; HUMANS; IMMEDIATE-EARLY PROTEINS; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 34548134145     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1143767     Document Type: Article

References (25)

1. A. Telenti, D. B. Goldstein, Nat. Rev. Microbiol. 4, 865 (2006).
2. S. J. O'Brien, G. W. Nelson, Nat. Genet. 36, 565 (2004).
3. A. Telenti, G. Bleiber, Future Virol. 1, 55 (2006).
4. M. Carrington, S. J. O'Brien, Annu. Rev. Med. 54, 535 (2003).
5. G. W. Nelson, S. J. O'Brien, J. Acquired Immune Defic. Syndr. 42, 347 (2006).
6. G. Bleiber et al., J. Virol. 79, 12674 (2005).
7. Materials and methods are available as supporting material on Science Online.
8. D. C. Douek, L. J. Picker, R. A. Koup, Annu. Rev. Immunol. 21, 265 (2003).
9. A. L. Price et al., Nat. Genet. 38, 904 (2006).
10. P. I. de Bakker et al., Nat. Genet. 38, 1166 (2006).
11. S. A. Migueles et al., Proc. Natl. Acad. Sci. U.S.A. 97, 2709 (2000).
12. M. Altfeld et al., AIDS 17, 2581 (2003).
13. J. K. Kulski, R. L. Dawkins, Immunogenetics 49, 404 (1999).
14. C. Vernet et al., Immunogenetics 38, 47 (1993).
15. J. R. Bailey et al., J. Exp. Med. 203, 1357 (2006).
16. J. Martinez-Picado et al., J. Virol. 80, 3617 (2006).
17. A. J. McMichael, S. L. Rowland-Jones, Nature 410, 980 (2001).
18. B. E. Stranger et al., PLoS Genet. 1, e78 (2005).
19. A. Michienzi et al., Proc. Natl. Acad. Sci. U.S.A. 97, 8955 (2000).
20. M. Dundr et al., J. Cell Sci. 108, 2811 (1995).
21. A. Ciuffi et al., J. Virol. 78, 10747 (2004).
22. G. B. Cohen et al., Immunity 10, 661 (1999).
23. P. J. Goulder et al., AIDS 11, 1884 (1997).
24. S. Adnan et al., Blood 108, 3414 (2006).
25. We thank R. Sahli (University of Lausanne, Switzerland). Funding was provided by the NIH-funded Center for HIV/AIDS Vaccine Immunology. J.F. is supported by the Swiss Foundation for Grants in Biology and Medicine, and A.T. is supported by Infectigen and the Swiss National Science Foundation.